Novavax Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1,065	682.16	983.71	1,982	1,146	475.6
Revenue Growth (YoY)	20.27%	-30.65%	-50.37%	72.89%	141.02%	2448.48%
Cost of Revenue	432.03	569.64	1,037	2,071	2,535	747.03
Gross Profit	632.62	112.52	-53.55	-89.48	-1,388	-271.43
Selling, General & Admin	194.93	323.59	457.45	488.69	298.36	142.59
Research & Development	20.87	20.87	41.21	66.57	-	-
Operating Expenses	215.8	344.45	498.66	555.26	298.36	142.59
Operating Income	416.82	-231.93	-552.21	-644.74	-1,687	-414.02
Interest Expense	-30.11	-20.08	-14.42	-19.88	-21.13	-15.15
Currency Exchange Gain (Loss)	3.3	-4.4	7.9	-2.5	-5.3	9.6
Other Non Operating Income (Expenses)	46.77	44.84	30	13.47	-1.53	4.01
EBT Excluding Unusual Items	436.79	-211.56	-528.73	-653.65	-1,715	-415.56
Merger & Restructuring Charges	-12.3	-17	-14.3	-	-	-2.7
Gain (Loss) on Sale of Assets	-45.09	51.95	-	-	-	-
Pretax Income	350.68	-176.62	-543.03	-653.65	-1,715	-418.26
Income Tax Expense	8.94	10.88	2.03	4.29	29.22	-
Net Income	341.75	-187.5	-545.06	-657.94	-1,744	-418.26
Net Income to Common	341.75	-187.5	-545.06	-657.94	-1,744	-418.26
Shares Outstanding (Basic)	161	152	101	78	74	58
Shares Outstanding (Diluted)	166	152	101	78	74	58
Shares Change (YoY)	16.16%	51.03%	28.89%	5.08%	29.27%	138.81%
EPS (Basic)	2.12	-1.23	-5.41	-8.42	-23.44	-7.27
EPS (Diluted)	2.07	-1.23	-5.41	-8.42	-23.44	-7.27
Free Cash Flow	-383.74	-100.32	-767.74	-504.99	268.45	-97.01
Free Cash Flow Per Share	-2.31	-0.66	-7.62	-6.46	3.61	-1.69
Gross Margin	59.42%	16.50%	-5.44%	-4.52%	-121.10%	-57.07%
Operating Margin	39.15%	-34.00%	-56.14%	-32.53%	-147.13%	-87.05%
Profit Margin	32.10%	-27.49%	-55.41%	-33.20%	-152.12%	-87.94%
Free Cash Flow Margin	-36.04%	-14.71%	-78.05%	-25.48%	23.42%	-20.40%
EBITDA	451.83	-183.44	-510.99	-615.68	-1,674	-409.13
EBITDA Margin	42.44%	-26.89%	-51.94%	-31.07%	-146.03%	-86.02%
D&A For EBITDA	35.01	48.5	41.23	29.05	12.66	4.89
EBIT	416.82	-231.93	-552.21	-644.74	-1,687	-414.02
EBIT Margin	39.15%	-34.00%	-56.14%	-32.53%	-147.13%	-87.05%
Revenue as Reported	1,065	682.16	983.71	1,982	1,146	475.6
Advertising Expenses	-	33.7	91.5	84	8.9	-

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q